Breaking News Instant updates and real-time market news.

MFGP

Micro Focus

$21.23

0.57 (2.76%)

, WFC

Wells Fargo

$45.45

0.15 (0.33%)

10:16
07/17/19
07/17
10:16
07/17/19
10:16

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Micro Focus (MFGP) downgraded to Sell from Neutral at Goldman Sachs. 2. Wells Fargo (WFC) downgraded to Neutral from Outperform at Macquarie. 3. Alliance Resource Partners (ARLP) downgraded to Neutral from Buy at B. Riley FBR with analyst Lucas Pipes citing the company's "disappointing" sales volumes in Q2 for the downgrade. 4. 58.com (WUBA) downgraded to Neutral from Outperform at Credit Suisse. 5. Ralph Lauren (RL), Levi Strauss (LEVI), and PVH Corp. (PVH) downgraded to Sell from Neutral at Goldman Sachs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MFGP

Micro Focus

$21.23

0.57 (2.76%)

WFC

Wells Fargo

$45.45

0.15 (0.33%)

ARLP

Alliance Resource Partners

$16.87

-0.38 (-2.20%)

WUBA

58.com

$57.07

-0.68 (-1.18%)

RL

Ralph Lauren

$111.09

-4.07 (-3.53%)

LEVI

Levi Strauss

$18.76

-1.05 (-5.30%)

PVH

PVH Corp.

$89.89

-2.61 (-2.82%)

  • 26

    Jul

  • 30

    Jul

  • 01

    Aug

  • 19

    Sep

  • 19

    Sep

  • 12

    Oct

  • 15

    Oct

MFGP Micro Focus
$21.23

0.57 (2.76%)

04/04/19
SBSH
04/04/19
DOWNGRADE
SBSH
Sell
Micro Focus downgraded to Sell from Neutral at Citi
Citi analyst Amit Harchandani downgraded Micro Focus to Sell from Neutral with a price target of 1,700 pence. The stock has run ahead of fundamentals, Harchandani tells investors in a research note. Further, the analyst sees downside risk to the company's revenue growth outlook.
07/16/19
GSCO
07/16/19
DOWNGRADE
GSCO
Sell
Micro Focus downgraded to Sell from Neutral at Goldman Sachs
04/12/19
LEHM
04/12/19
DOWNGRADE
LEHM
Equal Weight
Micro Focus downgraded to Equal Weight from Overweight at Barclays
Barclays analyst James Goodman downgraded Micro Focus International to Equal Weight from Overweight while raising his price target for the shares to GBP 20 from GBP 18.
01/28/19
GSCO
01/28/19
DOWNGRADE
GSCO
Neutral
Micro Focus downgraded to Neutral from Buy at Goldman Sachs
WFC Wells Fargo
$45.45

0.15 (0.33%)

07/17/19
BMOC
07/17/19
NO CHANGE
Target $59
BMOC
Market Perform
Wells Fargo price target lowered to $59 from $63 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Wells Fargo to $59 and kept his Market Perform rating after its operating expense-driven miss in Q2. The analyst also lowers his FY19 and FY20 EPS views by 9c and 37c to $4.40 and $5.20 respectively given the bank's lower net interest income and higher costs. Fotheringham contands that although Wells Fargo shares trade "well below" their average historical multiples, value investors should stay away until there is an update on guidance from a permanent CEO and the Fed gives more clarity on the timing of potential lifting of the bank's asset cap.
07/17/19
MACQ
07/17/19
DOWNGRADE
MACQ
Neutral
Wells Fargo downgraded to Neutral from Outperform at Macquarie
07/12/19
07/12/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) downgraded to Neutral from Buy at Citi. 2. Rexnord (RXN) was downgraded to Underperform from Buy at BofA/Merrill while Parker-Hannifin (PH) was downgraded to Neutral from Buy. 3. Instructure (INST) downgraded to Market Perform from Outperform at Raymond James with analyst Brian Peterson saying his rating change "in no way reflects any incremental concerns about the company's strategic direction," but is entirely about his more cautious view on 2020 growth projections. 4. MSC Industrial (MSM) downgraded to Neutral from Buy at Northcoast with analyst Tom Hayes citing the company's report of weaker than expected organic sales growth and margin headwinds in Q3. 5. Charles Schwab (SCHW) was downgraded to Neutral from Buy at BofA/Merrill and to Market Perform from Outperform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.
ARLP Alliance Resource Partners
$16.87

-0.38 (-2.20%)

07/17/19
RILY
07/17/19
DOWNGRADE
Target $20
RILY
Neutral
Alliance Resource Partners downgraded to Neutral from Buy at B. Riley FBR
B. Riley FBR analyst Lucas Pipes downgraded Alliance Resource Partners to Neutral from Buy and lowered his price target for the shares to $20 from $22. The analyst cites the company's "disappointing" sales volumes in Q2 for the downgrade.
07/09/19
CLKS
07/09/19
INITIATION
Target $20
CLKS
Buy
Alliance Resource Partners initiated with a Buy at Clarksons Platou
Clarksons Platou analyst Daniel Scott initiated Alliance Resource Partners with a Buy rating and $20 price target.
WUBA 58.com
$57.07

-0.68 (-1.18%)

03/04/19
MACQ
03/04/19
DOWNGRADE
MACQ
Neutral
58.com downgraded to Neutral from Outperform at Macquarie
03/27/19
DBAB
03/27/19
INITIATION
Target $67
DBAB
Hold
58.com initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Eileen Deng started 58.com with a Hold rating and $67 price target. The analyst expects 58.com's dominant position in online "blue-collar recruitment to serve as a clear driver of revenue growth." However, she sees bigger near-term uncertainties from the impact of macro headwinds on the job market, a slow property market, and rising competition from vertical players.
07/16/19
FBCO
07/16/19
DOWNGRADE
FBCO
Neutral
58.com downgraded to Neutral from Outperform at Credit Suisse
04/15/19
DBAB
04/15/19
NO CHANGE
DBAB
58.com added catalyst call Buy at Deutsche Bank
RL Ralph Lauren
$111.09

-4.07 (-3.53%)

05/14/19
COWN
05/14/19
NO CHANGE
COWN
Skechers, G-III among apparel names with outsized tariff risk, says Cowen
Cowen analyst John Kernan said 34% of apparel and about 70% of footwear imported into the U.S. come from China, adding that 25% tariffs on apparel and footwear will create "major disruption" at a time when companies are already facing accelerating disruption from technology and Amazon (AMZN). The analyst, who thinks diversifying from China sourcing will be slow, said he views Skechers (SKX), G-III Apparel (GIII), Carter's (CRI), PVH Corp. (PVH) and Ralph Lauren (RL) as among the apparel stocks with outsized EPS risk. He added that he thinks companies like Under Armour (UAA), that may have lower than sector average exposure to China sourcing but also have lower EBIT margins, as faced with greater sensitivity to higher cost of goods.
05/15/19
RBCM
05/15/19
NO CHANGE
Target $135
RBCM
Outperform
Ralph Lauren price target lowered to $135 from $145 at RBC Capital
RBC Capital analyst Kate Fitzsimmons lowered her price target on Ralph Lauren to $135 after its Q4 results to reflect the weaker North America sales but also kept her Outperform rating, saying the earnings and revenue beat in the quarter affirm that the efforts to diversify the company's business overseas are "taking hold". The analyst also believes that Ralph Lauren's FY20 gross margin outlook was deliberately conservative and expects the company to make progress toward its mid-teen margin target as its SG&A spending gathers leverage.
07/17/19
GSCO
07/17/19
DOWNGRADE
Target $19
GSCO
Sell
Levi Strauss downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded Levi Strauss (LEVI) to Sell from Neutral and lowered her price target for the shares to $19 from $21. The stock closed Tuesday down 33c to $19.80. The analyst, who also downgraded Ralph Lauren (RL) and PVH Corp. (PVH) this morning to Sell, expects headwinds for wholesale-led apparel brands to intensify in the second half of 2019. Walvis forecasts "ongoing superior brand momentum" and growth at Levi relative to peers, but beeves this is well understood by investors. Further, recent results show that the company is not immune from U.S. wholesale challenges, the analyst tells investors in a research note. Despite this, Levi's relative valuation multiple has expanded versus peers, which is unwarranted, contends Walvis.
07/17/19
GSCO
07/17/19
DOWNGRADE
Target $103
GSCO
Sell
Ralph Lauren downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded Ralph Lauren to Sell from Neutral and lowered her price target for the shares to $103 from $124. The analyst expects headwinds for wholesale-led apparel brands to intensify in the second half of 2019. The Street has become "overly optimistic" on a near-term growth inflection at Ralph Lauren, Walvis tells investors in a research note. She believes intensifying U.S. wholesale sector challenges will offset incremental gains from the company's turnaround execution.
LEVI Levi Strauss
$18.76

-1.05 (-5.30%)

04/15/19
TLSY
04/15/19
INITIATION
Target $28
TLSY
Outperform
Levi Strauss initiated with an Outperform at Telsey Advisory
Telsey Advisory initiated Levi Strauss with an Outperform and $28 price target.
04/15/19
04/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Pinterest (PINS) initiated with a Neutral at DA Davidson. 2. Five Below (FIVE) initiated with a Buy at BofA/Merrill. 3. Levi Strauss (LEVI) initiated with an Outperform at Telsey Advisory, an Overweight at JPMorgan, a Buy at Citi and Guggenheim, an Equal Weight at Morgan Stanley, and a Neutral at Goldman Sachs and BofA/Merrill. 4. Tocagen (TOCA) initiated with a Market Perform at SVB Leerink. 5. Alcon (ALC) initiated with a Buy at Jefferies, while Allergan (AGN) was initiated with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/19
JPMS
07/10/19
NO CHANGE
JPMS
Overweight
Levi 'beat and raise' potential remains after 'high quality' Q2, says JPMorgan
JPMorgan analyst Matthew Boss reiterated an Overweight rating on Levi Strauss after the company reported adjusted Q2 EPS of 17c, which he notes was 4c above the "apples-to-apples" Wall Street consensus of 13c, and raised its FY19 top-line guidance to the "high-end" of its mid-single-digit prior constant currency growth forecast. Boss told investors in a post-earnings recap that he believes the quality of Q2 was "high," driven by the combination of constant currency revenue growth of 9% and "healthy" inventories exiting the quarter, and he also sees continued "beat & raise" opportunity in the second half of the year.
PVH PVH Corp.
$89.89

-2.61 (-2.82%)

07/17/19
GSCO
07/17/19
DOWNGRADE
Target $82
GSCO
Sell
PVH Corp. downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded PVH Corp. to Sell from Neutral and lowered her price target for the shares to $82 from $101. The analyst expects headwinds for wholesale-led apparel brands to intensify in the second half of 2019. Specifically, she forecasts ongoing headwinds at Calvin Klein, expects Tommy Hilfiger growth to fade, and sees risk to total company results given PVH's "heavy exposure" to North America wholesale and outlet channels.
07/17/19
GSCO
07/17/19
DOWNGRADE
Target $82
GSCO
Sell
PVH Corp. downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis downgraded PVH Corp. to Sell from Neutral and lowered her price target for the shares to $82 from $101. The analyst expects headwinds for wholesale-led apparel brands to intensify in the second half of 2019. Specifically, she forecasts ongoing headwinds at Calvin Klein, expects Tommy Hilfiger growth to fade, and sees risk to total company results given PVH's "heavy exposure" to North America wholesale and outlet channels.
07/15/19
RBCM
07/15/19
NO CHANGE
Target $125
RBCM
Outperform
PVH Corp 'pricing in skepticism', says RBC Capital
RBC Capital analyst Kate Fitzsimmons keeps her Outperform rating and $125 price target on PVH Corp, saying that while the company offers several drivers for sequential improvement in the second half of the year, the stock is "pricing in skepticism" at 8-times her expected FY20 earnings. The analyst cites the company's product and marketing initiatives, contributions from its acquisitions and easier comps, with an added "kicker" of margin recovery at its Calvin Klein brand. Fitzsimmons contends that PVH Corp stock offers a "favorable" risk-reward.

TODAY'S FREE FLY STORIES

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

19:49
10/13/19
10/13
19:49
10/13/19
19:49
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

FB

Facebook

$184.20

4.02 (2.23%)

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

T

AT&T

$37.58

0.17 (0.45%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

K

Kellogg

$62.14

-0.27 (-0.43%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

19:42
10/13/19
10/13
19:42
10/13/19
19:42
Initiation
IGM Biosciences initiated  »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

19:37
10/13/19
10/13
19:37
10/13/19
19:37
Hot Stocks
LeMaitre acquires biologic patch business from Admedus »

LeMaitre Vascular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

18:37
10/13/19
10/13
18:37
10/13/19
18:37
Periodicals
SoftBank seeking control of WeWork through financing package, WSJ says »

SoftBank (SFTBY) has…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

18:34
10/13/19
10/13
18:34
10/13/19
18:34
Hot Stocks
Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:29
10/13/19
10/13
18:29
10/13/19
18:29
Recommendations
Adverum Biotechnologies analyst commentary at Piper Jaffray »

Adverum '022 looking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:23
10/13/19
10/13
18:23
10/13/19
18:23
Hot Stocks
Adverum Biotechnologies reports additional data from Phase 1 trial of ADVM-022 »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$56.41

0.55 (0.98%)

18:03
10/13/19
10/13
18:03
10/13/19
18:03
Hot Stocks
ConocoPhillips announces $1.39B agreement to sell interests in Australia-West »

ConocoPhillips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

T

AT&T

$37.58

0.17 (0.45%)

, CMCSA

Comcast

$45.53

1.02 (2.29%)

17:18
10/13/19
10/13
17:18
10/13/19
17:18
On The Fly
Box Office Battle: 'Joker' stays at number 1 with another $55M »

"Box Office Battle" is…

T

AT&T

$37.58

0.17 (0.45%)

CMCSA

Comcast

$45.53

1.02 (2.29%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$58.16

0.83 (1.45%)

LGF.A

Lionsgate

$9.52

0.22 (2.37%)

LGF.B

Lionsgate

$8.97

0.19 (2.16%)

DIS

Disney

$130.08

0.73 (0.56%)

VIAB

Viacom

$23.02

0.505 (2.24%)

VIA

Viacom

$25.45

0.65 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

PCG

PG&E

$8.08

0.3 (3.86%)

16:48
10/13/19
10/13
16:48
10/13/19
16:48
Periodicals
PG&E turns down San Francisco's $2.5B offer to acquire assets, Reuters says »

PG&E rejected a $2.5B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

16:44
10/13/19
10/13
16:44
10/13/19
16:44
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

FB

Facebook

$184.20

4.02 (2.23%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Periodicals
Warren buying Facebook ads claiming Zuckerberg backs Trump, Bloomberg says »

Elizabeth Warren is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 30

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

BX

Blackstone

$47.10

0.62 (1.33%)

16:34
10/13/19
10/13
16:34
10/13/19
16:34
Periodicals
Blackstone discussed with Citadel about buying stake, WSJ reports »

Blackstone has held talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

16:29
10/13/19
10/13
16:29
10/13/19
16:29
Periodicals
Google bars high-interest consumer loan services from app store, WSJ reports »

Google has barred…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

16:28
10/13/19
10/13
16:28
10/13/19
16:28
General news
Trump working with Congress on 'powerful' Turkey sanctions »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

16:23
10/13/19
10/13
16:23
10/13/19
16:23
Hot Stocks
Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies »

Allergan and Molecular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$39.49

1.8 (4.78%)

, UBER

Uber

$30.09

1.19 (4.12%)

16:04
10/13/19
10/13
16:04
10/13/19
16:04
Periodicals
Lyft sues NYC over cruising time caps, Reuters reports »

Following its rival…

LYFT

Lyft

$39.49

1.8 (4.78%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated at Wells Fargo »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

LLY

Eli Lilly

$108.37

1.54 (1.44%)

14:15
10/13/19
10/13
14:15
10/13/19
14:15
Hot Stocks
Eli Lilly says Taltz met co-primary endpoints in Phase 3 plaque psoriasis study »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.